Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value-Based Cancer Care

- PMLiVE

UK-Senegal partners plan to validate ten-minute COVID-19 diagnostic

Rapid test kit will aim to curb virus' spread across Africa

- PMLiVE

The role of women in science and technology

Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed

- PMLiVE

Merck gets first approval for MET inhibitor tepotinib in Japan

First worldwide approval for MET inhibitor

- PMLiVE

NHS to set up hospital in ExCeL Centre as coronavirus cases grow

Over half a million people have also volunteered with the health service

- PMLiVE

McCann Health France strengthens team with two new hires

Melissa Brunet and Christelle David-Basei join the agency

AstraZeneca AZ

AstraZeneca forms $2bn gene silencing pact with Silence Tx

Collaboration focuses on cardiovascular, renal, metabolic and respiratory disease

- PMLiVE

UPDATED: Gilead drops remdesivir’s orphan drug designation

Decision comes amid intense public criticism of the regulatory status

- PMLiVE

Policy and public health: ML and AI in healthcare

What are the hurdles for machine learning and artificial intelligence in pharma?

Roche Basel Switzerland

FDA approves Roche’s Actemra COVID-19 trial

Plans to initiate trial in early April

- PMLiVE

FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes

Formally rejects extended use of SGLT2 inhibitor

- PMLiVE

Lilly halts most clinical trials as coronavirus disruption continues

Will continue ongoing trials for patients who are already enrolled

- PMLiVE

Novartis says data backs safety of on-hold intrathecal Zolgensma

Data also demonstrated 'remarkable' efficacy in SMA type 2

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links